| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 2.703.b | Amgros I/S | Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Sun Pharmaceuticals Germany GmbH, Accord Healthcare AB, Zentiva Denmark ApS, Accord Healthcare AB, STADA Nordic ApS, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Pierre Fabre Pharma Norden AB, Norgine Danmark A/S, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Norgine Danmark A/S, Abacus Medicine A/S, Orifarm A/S, STADA Nordic ApS | 256.349.795 kr. | 13. oktober 2026 |
| Amgros 2027 1.703.b | Amgros I/S | Ferring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Norgine Danmark A/S, Orifarm Generics A/S, Norgine Danmark A/S | 123.449.077 kr. | 12. oktober 2026 |
| Amgros 2027 1.703.b | Amgros I/S | Ferring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Norgine Danmark A/S, Orifarm Generics A/S, Norgine Danmark A/S | 123.449.077 kr. | 12. oktober 2026 |
| Amgros 2027 1.703.b | Amgros I/S | Ferring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Norgine Danmark A/S, Orifarm Generics A/S, Norgine Danmark A/S | 123.449.077 kr. | 12. oktober 2026 |
| Rammeaftale om køb af Pedmarqsi (natriumthiosulfat) | Amgros I/S | Norgine Danmark A/S | 32.000.000 kr. | 22. marts 2026 |